Clinical Trials in Salt Lake City

Showing 5681-5700 of 16,694 trials

A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-993

NCT06508762

The purpose of the study is to evaluate the pharmacokinetics (PK), safety, and tolerability of VX-993 in healthy adult participants.

Pain

Vertex Pharmaceuticals Incorporated24 participantsStarted Jul 2024

Salt Lake City, Utah, United States

COMPLETEDNA< 1 mile

Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke

NCT03741400

The Virtual Reality Glove for Hand and Arm Rehabilitation (vREHAB) trial is a randomized, controlled, phase 3 trial aiming to evaluate the safety, usability, and efficacy of a virtual reality biofeedback system (Neofect RAPAEL Smart Glove) to promote recovery of distal arm and hand function in the acute and subacute period after stroke, as compared to standard of care therapy. The aims of the study is to demonstrate: 1. the effect of Smart Glove use on functional recovery, in addition to standard of care rehabilitation therapy. 2. the feasibility of increasing the dose of rehabilitation in acute stroke patients with the Smart Glove. 3. the effect of Smart Glove use on quality of life.

Stroke, AcuteCerebral Infarction

Stanford University60 participantsStarted Oct 2018

Palo Alto, California, United States • San Jose, California, United States • Salt Lake City, Utah, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

NCT03265288

An International Phase II, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of LAU-7b administered once-daily for 6 months for the treatment of CF.

Cystic Fibrosis

Laurent Pharmaceuticals Inc.166 participantsStarted Nov 2018

Long Beach, California, United States • Los Angeles, California, United States • Sacramento, California, United States +37 more locations

A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-993

Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Find Trials by Condition in Salt Lake City

The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

Atrasentan in Patients With IgA Nephropathy

Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)

REmodeling the Left Ventricle With Atrial Modulated Pacing

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors

This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)